Skip to main content
Asia Pacific
English
English
Filipino
Indonesian
Malay
Thai - ไทย
中文
msf_seeap website logo
Main navigation (Global)
News & Stories
Latest news and updates
Read the latest updates from our projects.
Blogs
Stories from our staff and patients
Issues in focus
Learn more about key issues and medical topics
MSF in the region
Updates from our projects in the Asia Pacific region
Media contacts
Contact details for media enquiries
Browse the latest stories
About Us
Who are we
Read about our worldwide medical projects
Our history
Learn more about the history of our organisation
Contact us
Our contact details for enquiries
SEEAP Supply Unit
Introduction to the Southeast, East Asia and Pacific (SEEAP) Supply Unit
Learn more about us
Take Action
Attend an event
Browse and register for upcoming events
Request a speaker
Request a speaker for your event
Engage on social media
Follow and engage with us on social media
Subscribe for updates
Subscribe for updates about our work
Partnership Opportunities
Partner with us to make an impact for people in need.
Islamic Giving
Providing Support through Islamic Giving
Legacy Giving
Give through your will
Donate to support our medical teams
Resources
General resources
View our latest downloadable resources.
Accountability Reports
Learn more about our response to emergencies
International Activity Reports
Browse our annual international activity reports.
Free Download: Wellness Activity Book
Search
✕
Close
Donation menu
Donate Now
Monthly giving
One-off giving
Donation FAQs
Careers
Who we need
Recruitment process
Essential criteria
Compensation and benefits
Security and safety
Recruitment FAQs
Apply Now
Search
News menu
Blogs
Project updates
Issues
(-)
Tuberculosis (TB)
Location
South Sudan
Myanmar
Philippines
Afghanistan
Belarus
Georgia
Guinea
India
Iraq
(-)
Lesotho
Niger
Nigeria
Pakistan
Papua New Guinea
Peru
South Africa
Sweden
Switzerland
Uganda
Year
2023
Reset filters
(-)
Tuberculosis (TB)
(-)
Lesotho
India
Landmark Clinical Trial Redefines Multidrug-Resistant Tuberculosis Treatment Options
endTB Clinical Trial Offers Multiple New Shortened Drug Regimens to Treat Adults and Children with Multidrug-Resistant Tuberculosis
Tuberculosis (TB)
